Results showed that PD98059, the specific inhibitor of MEK/ERK pathway, completely inhibited the BzATP-induced proliferation of glioma cells in U87 and U251 cell lines (Figures 7(a) and 7(b)). Here, MAP2K7 is linked to central nervous system cancer.